VBI Vaccines Appoints Blaine McKee to Board of Directors
January 16, 2019 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
Quick Cash Generation and Speed Are What Make Mergers with Troubled Companies Work—and Can Lead to Greater Rewards
November 19, 2018 16:44 ET
|
BCG
About 40% of Big-Company Mergers Require a Turnaround; Risks are Big, but Rewards Can be Greater, According to BCG TURN Report That Brings to Life Eight Successes BOSTON, Nov. 19, 2018 (GLOBE...
VBI Vaccines Appoints Christopher McNulty as Chief Financial Officer and Head of Business Development
August 15, 2018 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Aug. 15, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company, today announced the appointment of Christopher McNulty as...
MIT Enterprise Forum of Cambridge Presents a Keynote Address by Chris Viehbacher, CEO of Sanofi-aventis
April 06, 2011 10:35 ET
|
MIT Enterprise Forum of Cambridge
CAMBRIDGE, MA--(Marketwire - April 6, 2011) - On April 11, the MIT Enterprise Forum of Cambridge will feature a keynote by Chris Viehbacher, CEO of Sanofi-aventis. Headquartered in Paris, France,...